Seroussi Brigitte
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Seroussi Brigitte has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
Bouaud Jacques
AP-HP, DRCI, Paris, France
7 shared publications- Jean-Baptiste Lamy
Sorbonne Université, INSERM, Université Sorbonne Paris Nord, LIMICS, Paris France
4 shared publications GuÉZennec Gilles
Sorbonne Université, Université Paris 13, Sorbonne Paris Cité, INSERM, UMR S_1142, LIMICS, Paris, France
3 shared publicationsPrebet Coralie
AP-HP, Hôpital Tenon, Paris, France
2 shared publications- Abdelmalek Mouazer
Laboratory of Medical Informatics and Knowledge Engineering in e-Health INSERM Université Sorbonne Paris Nord Sorbonne Université LIMICS Paris France
1 shared publication - Booma Devi Sekar
School of Mathematics and Physics, Queens University Belfast, Belfast, U.K.
1 shared publication
Latest Publications
- Open Access
- 12 April 2025
- Published by Springer Nature
- p. 241-268
Green IT to Reduce Healthcare’s Climate Impact: The French Approach
- 12 April 2025
- Published by Springer Nature
- p. 241-268
Open AccessGreen IT to Reduce Healthcare’s Climate Impact: The French Approach
- Open Access
A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management
Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines and on the visual presentation of aggregated drug knowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial, each pharmacist performing a medication review for two fictitious patients without ABiMed, and two others with ABiMed. We recorded the problems identified by the pharmacists, the interventions proposed, the response time, the perceived usability and the comments. Pharmacists' medication reviews were compared to an expert-designed gold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant drug-related problems during the medication review (p=1.1e-12) and proposed better interventions (p=9.8e-9), without needing more time (p=0.56). The System Usability Scale score is 82.7, which is ranked "excellent". In their comments, pharmacists appreciated the visual aspect of ABiMed and its ability to compare the current treatment with the proposed one. A multifactor analysis showed no difference in the support offered by ABiMed according to the pharmacist's age or sex, in terms of percentage of problems identified or quality of the proposed interventions. Conclusions: The use of an intelligent and visual clinical decision support system can help pharmacists when they perform medication reviews. Our main perspective is the validation of the system in clinical conditions.
Open AccessA randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management
Background: Medication review is a structured interview of the patient, performed by the pharmacist and aimed at optimizing drug treatments. In practice, medication review is a long and cognitively-demanding task that requires specific knowledge. Clinical practice guidelines have been proposed, but their application is tedious. Methods: We designed ABiMed, a clinical decision support system for medication reviews, based on the implementation of the STOPP/START v2 guidelines and on the visual presentation of aggregated drug knowledge using tables, graphs and flower glyphs. We evaluated ABiMed with 39 community pharmacists during a randomized simulation trial, each pharmacist performing a medication review for two fictitious patients without ABiMed, and two others with ABiMed. We recorded the problems identified by the pharmacists, the interventions proposed, the response time, the perceived usability and the comments. Pharmacists' medication reviews were compared to an expert-designed gold standard. Results: With ABiMed, pharmacists found 1.6 times more relevant drug-related problems during the medication review (p=1.1e-12) and proposed better interventions (p=9.8e-9), without needing more time (p=0.56). The System Usability Scale score is 82.7, which is ranked "excellent". In their comments, pharmacists appreciated the visual aspect of ABiMed and its ability to compare the current treatment with the proposed one. A multifactor analysis showed no difference in the support offered by ABiMed according to the pharmacist's age or sex, in terms of percentage of problems identified or quality of the proposed interventions. Conclusions: The use of an intelligent and visual clinical decision support system can help pharmacists when they perform medication reviews. Our main perspective is the validation of the system in clinical conditions.
- 1 August 2020
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 108, 101922
Implementation of an ontological reasoning to support the guideline-based management of primary breast cancer patients in the DESIREE project
- 1 August 2020
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 108, 101922
Implementation of an ontological reasoning to support the guideline-based management of primary breast cancer patients in the DESIREE project
- Open Access
- 1 January 2020
- Published by IOS Press
- Vol. 270, 698-702
Update on the DMP, the French Nationally Shared Medical Record: Did We Make It?
Different countries have solved the problem of care coordination by implementing a nationwide centralized framework of clinical information sharing with "new" secure online care records stored in specifically created platforms. The French DMP initially launched in 2006, relaunched in 2010, and re-relaunched in 2016 follows this model. After a difficult start and some governmental actions to promote its adoption, the DMP has been nationally deployed in November 2018. New features have been developed (creation of DMPs for children, management of minors' rights, addition of living wills, notification of the first access of any healthcare professional), and financial incentive measures have been implemented. In September 2019, over seven million people had a DMP in France. In 18 months, we observed a significant increase of GPs feeding (from 0.7% to 20.9%) and consulting (from 1.6% to 44.8%) DMPs.
- 1 January 2020
- Published by IOS Press
- Vol. 270, 698-702
Open AccessUpdate on the DMP, the French Nationally Shared Medical Record: Did We Make It?
Different countries have solved the problem of care coordination by implementing a nationwide centralized framework of clinical information sharing with "new" secure online care records stored in specifically created platforms. The French DMP initially launched in 2006, relaunched in 2010, and re-relaunched in 2016 follows this model. After a difficult start and some governmental actions to promote its adoption, the DMP has been nationally deployed in November 2018. New features have been developed (creation of DMPs for children, management of minors' rights, addition of living wills, notification of the first access of any healthcare professional), and financial incentive measures have been implemented. In September 2019, over seven million people had a DMP in France. In 18 months, we observed a significant increase of GPs feeding (from 0.7% to 20.9%) and consulting (from 1.6% to 44.8%) DMPs.
- Open Access
- 1 January 2019
- Published by IOS Press
- Vol. 258, 60-64
Using the Recommendations Inferred by a Decision Support System to Compare Breast Cancer Clinical Practice Guidelines
Numerous studies have reported that inconsistencies exist between clinical practice guidelines (CPGs) elaborated on the same topic and at the same date. These results are usually established from the analyses handled on narrative CPGs or on their semi-structured version. In the context of the European-funded DESIREE project, we have developed a guideline-based decision support system embedding various contemporary CPGs on breast cancer management. We have run the GL-DSS on a sample of 571 retrospective clinical cases and specifically assessed the level of inconsistencies between the recommendations issued by the US National Comprehensive Cancer Network (NCCN) Guidelines for Breast Cancer and those issued by Assistance Publique – Hôpitaux de Paris (AP-HP, France) CPGs. We proposed a typology with six different situations from total incompatibility to complete identity as a result of the comparison of NCCN and AP-HP CPGs for each clinical case. It was interesting to observe that we got 38% of inconsistencies with 3% of total incompatibility, and 62% of similarity with 0% of complete identity. The silence of one CPG was resolved by the other CPG providing recommendations in 21% of the cases.
- 1 January 2019
- Published by IOS Press
- Vol. 258, 60-64
Open AccessUsing the Recommendations Inferred by a Decision Support System to Compare Breast Cancer Clinical Practice Guidelines
Numerous studies have reported that inconsistencies exist between clinical practice guidelines (CPGs) elaborated on the same topic and at the same date. These results are usually established from the analyses handled on narrative CPGs or on their semi-structured version. In the context of the European-funded DESIREE project, we have developed a guideline-based decision support system embedding various contemporary CPGs on breast cancer management. We have run the GL-DSS on a sample of 571 retrospective clinical cases and specifically assessed the level of inconsistencies between the recommendations issued by the US National Comprehensive Cancer Network (NCCN) Guidelines for Breast Cancer and those issued by Assistance Publique – Hôpitaux de Paris (AP-HP, France) CPGs. We proposed a typology with six different situations from total incompatibility to complete identity as a result of the comparison of NCCN and AP-HP CPGs for each clinical case. It was interesting to observe that we got 38% of inconsistencies with 3% of total incompatibility, and 62% of similarity with 0% of complete identity. The silence of one CPG was resolved by the other CPG providing recommendations in 21% of the cases.
- Open Access
- 1 January 2018
- Published by IOS Press
- Vol. 255, 190-194
Implementing Guideline-Based, Experience-Based, and Case-Based Approaches to Enrich Decision Support for the Management of Breast Cancer Patients in the DESIREE Project
DESIREE is a European-funded project to improve the management of primary breast cancer. We have developed three decision support systems (DSSs), a guideline-based, an experience-based, and a case-based DSSs, resp. GL-DSS, EXP-DSS, and CB-DSS, that operate simultaneously to offer an enriched multi-modal decision support to clinicians. A breast cancer knowledge model has been built to describe within a common ontology the data model and the termino-ontological knowledge used for representing breast cancer patient cases. It allows for rule-based and subsumption-based reasoning in the GL-DSS to provide best patient-centered reconciled care plans. It also allows for using semantic similarity in the retrieval algorithm implemented in the CB-DSS. Rainbow boxes are used to display patient cases similar to a given query patient. This innovative visualization technique translates the question of deciding the most appropriate treatment into a question of deciding the colour dominance among boxes.
- 1 January 2018
- Published by IOS Press
- Vol. 255, 190-194
Open AccessImplementing Guideline-Based, Experience-Based, and Case-Based Approaches to Enrich Decision Support for the Management of Breast Cancer Patients in the DESIREE Project
DESIREE is a European-funded project to improve the management of primary breast cancer. We have developed three decision support systems (DSSs), a guideline-based, an experience-based, and a case-based DSSs, resp. GL-DSS, EXP-DSS, and CB-DSS, that operate simultaneously to offer an enriched multi-modal decision support to clinicians. A breast cancer knowledge model has been built to describe within a common ontology the data model and the termino-ontological knowledge used for representing breast cancer patient cases. It allows for rule-based and subsumption-based reasoning in the GL-DSS to provide best patient-centered reconciled care plans. It also allows for using semantic similarity in the retrieval algorithm implemented in the CB-DSS. Rainbow boxes are used to display patient cases similar to a given query patient. This innovative visualization technique translates the question of deciding the most appropriate treatment into a question of deciding the colour dominance among boxes.
- Open Access
- 1 January 2018
- Published by IOS Press
- Vol. 247, 755-759
Taking into Account the Complementarity of Contemporary Breast Cancer Guidelines to Leverage Decision Support in the DESIREE Project
Breast cancer is one of the most common cancers in Western countries and the first cause of death among women in France. Studies have reported that the compliance of the treatment with breast cancer clinical practice guidelines (CPGs) is accompanied with a significant improvement of recurrence-free survival and overall survival rates. However, compliance of multidisciplinary tumour board decisions with CPGs remains non-satisfactory. The European project DESIREE aims at building a software package to support the guideline-based management of breast cancer patients. The aim is to select multiple relevant contemporary CPGs published on the management of breast cancer and to concurrently apply them to benefit of the complementarity of the recommendations issued, and leverage the guideline-based decision support. We used a clinical case to compare NCCN and ESMO CPGs in terms of concordance, complementarity, and conflicts. Out of the 757 decision rules extracted from both CPGs, 64 rules were triggered (32 from NCCN, and 32 from ESMO) by the clinical case. Ten rules were concordant, 52 complementary, and two conflicting. Complementarity relies on the different levels of granularity of the IF-parts of the rules that lead to different specific THEN-parts. Another type of complementarity comes from the provision of specific care apart from the breast cancer therapeutic management. The few inter- and intra-CPGs conflicts show the limits of CPGs in particular situations still debated by medical research.
- 1 January 2018
- Published by IOS Press
- Vol. 247, 755-759
Open AccessTaking into Account the Complementarity of Contemporary Breast Cancer Guidelines to Leverage Decision Support in the DESIREE Project
Breast cancer is one of the most common cancers in Western countries and the first cause of death among women in France. Studies have reported that the compliance of the treatment with breast cancer clinical practice guidelines (CPGs) is accompanied with a significant improvement of recurrence-free survival and overall survival rates. However, compliance of multidisciplinary tumour board decisions with CPGs remains non-satisfactory. The European project DESIREE aims at building a software package to support the guideline-based management of breast cancer patients. The aim is to select multiple relevant contemporary CPGs published on the management of breast cancer and to concurrently apply them to benefit of the complementarity of the recommendations issued, and leverage the guideline-based decision support. We used a clinical case to compare NCCN and ESMO CPGs in terms of concordance, complementarity, and conflicts. Out of the 757 decision rules extracted from both CPGs, 64 rules were triggered (32 from NCCN, and 32 from ESMO) by the clinical case. Ten rules were concordant, 52 complementary, and two conflicting. Complementarity relies on the different levels of granularity of the IF-parts of the rules that lead to different specific THEN-parts. Another type of complementarity comes from the provision of specific care apart from the breast cancer therapeutic management. The few inter- and intra-CPGs conflicts show the limits of CPGs in particular situations still debated by medical research.
- Open Access
- 1 January 2018
- Published by IOS Press
- Vol. 247, 256-260
The (Re)-Relaunching of the DMP, the French Shared Medical Record: New Features to Improve Uptake and Use
Health care delivery for patients with chronic conditions is complex and confusing. Care is often fragmented, less effective, and sometimes harmful. Given the potential for EHRs and other health IT systems to facilitate information flow between providers, patients, and settings, health IT-based measures are of particular interest for care coordination. Health information exchange (HIE) has the potential to improve the quality of healthcare by enabling providers with better access to patient information from multiple sources at the point of care. However, many barriers to HIE use have been reported. Another solution relies on the implementation of a nationwide centralized framework of clinical information sharing with “new” secure online care records stored in specifically created platforms. The French DMP follows this model but the adoption of the tool has been historically poor. In 2016, a renovation of the DMP program was launched in nine pilot French departments and new features have been implemented: the DMP content has been fully specified, patients can create their DMP by themselves, DMPs are automatically filled in by data claims, a mobile app has been developed, and technical issues about DMP and EHRs interoperability have been resolved. In October 2017, over 900,000 people have a DMP with an average new DMP being created every minute. These results have to be confirmed in 2018 when the new DMP will be deployed on the whole French territory.
- 1 January 2018
- Published by IOS Press
- Vol. 247, 256-260
Open AccessThe (Re)-Relaunching of the DMP, the French Shared Medical Record: New Features to Improve Uptake and Use
Health care delivery for patients with chronic conditions is complex and confusing. Care is often fragmented, less effective, and sometimes harmful. Given the potential for EHRs and other health IT systems to facilitate information flow between providers, patients, and settings, health IT-based measures are of particular interest for care coordination. Health information exchange (HIE) has the potential to improve the quality of healthcare by enabling providers with better access to patient information from multiple sources at the point of care. However, many barriers to HIE use have been reported. Another solution relies on the implementation of a nationwide centralized framework of clinical information sharing with “new” secure online care records stored in specifically created platforms. The French DMP follows this model but the adoption of the tool has been historically poor. In 2016, a renovation of the DMP program was launched in nine pilot French departments and new features have been implemented: the DMP content has been fully specified, patients can create their DMP by themselves, DMPs are automatically filled in by data claims, a mobile app has been developed, and technical issues about DMP and EHRs interoperability have been resolved. In October 2017, over 900,000 people have a DMP with an average new DMP being created every minute. These results have to be confirmed in 2018 when the new DMP will be deployed on the whole French territory.
- Open Access
- 1 January 2018
- Published by Springer Nature in International Journal of Computational Intelligence Systems
- Vol. 12 (1) , 28-38
Case-Based Decision Support System for Breast Cancer Management
- 1 January 2018
- Published by Springer Nature in International Journal of Computational Intelligence Systems
- Vol. 12 (1) , 28-38
Open AccessCase-Based Decision Support System for Breast Cancer Management
- Open Access
- 1 January 2017
- Published by IOS Press
- Vol. 245, 1148-1152
Using Therapeutic Circles to Visualize Guideline-Based Therapeutic Recommendations for Patients with Multiple Chronic Conditions: A Case Study with GO-DSS on Hypertension, Type 2 Diabetes, and Dyslipidemia
Clinical decision support systems (CDSSs) have proven to potentially improve the compliance of physician decisions with clinical practice guidelines (CPGs). However, actual patients suffer from multiple conditions and CPGs that are usually single-disease-focused provide disease-specific recommendations with no support on how to manage adverse interactions between the recommended treatments. We have developed GO-DSS, a CDSS that implements an ontological reasoning process to perform CPG reconciliation. GO-DSS is applied to the concurrent management of hypertension, type 2 diabetes, and dyslipidemia. We proposed an innovative graphical interface to display medication recommendations as “therapeutic circles”. A qualitative evaluation of the system and of this graphical layout has been performed on simulated patient cases by a sample of 12 users with various backgrounds (think aloud method). The resulting usability of the system is highly appreciated with a mean rating of 90.7% according to the standardized System Usability Scale.
- 1 January 2017
- Published by IOS Press
- Vol. 245, 1148-1152
Open AccessUsing Therapeutic Circles to Visualize Guideline-Based Therapeutic Recommendations for Patients with Multiple Chronic Conditions: A Case Study with GO-DSS on Hypertension, Type 2 Diabetes, and Dyslipidemia
Clinical decision support systems (CDSSs) have proven to potentially improve the compliance of physician decisions with clinical practice guidelines (CPGs). However, actual patients suffer from multiple conditions and CPGs that are usually single-disease-focused provide disease-specific recommendations with no support on how to manage adverse interactions between the recommended treatments. We have developed GO-DSS, a CDSS that implements an ontological reasoning process to perform CPG reconciliation. GO-DSS is applied to the concurrent management of hypertension, type 2 diabetes, and dyslipidemia. We proposed an innovative graphical interface to display medication recommendations as “therapeutic circles”. A qualitative evaluation of the system and of this graphical layout has been performed on simulated patient cases by a sample of 12 users with various backgrounds (think aloud method). The resulting usability of the system is highly appreciated with a mean rating of 90.7% according to the standardized System Usability Scale.